(CSE: SURE) (OTCQB: SURNF), (Profile) through its subsidiary GlucaPharm Inc., is advancing a differentiated next-generation GLP-1 platform centered on GEP-44, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in one of the fastest-growing pharmaceutical markets in history
Foods that pack the most fiber per bite When you can only eat small portions, choose foods with the highest fiber density
Review Your Insurance Policy Start by reviewing your plans drug formulary
There is a sizeable range of severity in this disorder, so many refer to it as a spectrum
In citrulline malate, malic acid feeds into ATP production pathways, effectively giving your muscles more fuel to work with during training
Orforglipron is a non-peptide oral GLP-1 that could change accessibility entirely